Clomid (clomiphene citrate) NDC 0713-0885

NDC codes

FDA NDC Directory

Product NDC (as listed)0713-0885Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00713-0885Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0713-0885-09	00713088509	1 BLISTER PACK in 1 CARTON (0713-0885-09) / 10 TABLET in 1 BLISTER PACKMarketed from Sep 12, 2022
0713-0885-30	00713088530	3 BLISTER PACK in 1 CARTON (0713-0885-30) / 10 TABLET in 1 BLISTER PACKMarketed from Sep 9, 2022

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Clomid
Generic name (nonproprietary): clomiphene citrate
Active ingredients: Clomiphene citrate — 50 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Cosette Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 075528
Marketing start: Sep 9, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Selective Estrogen Receptor Modulators (Mechanism)
Identifiers: Product ID 0713-0885_2d02613b-bc31-bf2c-e063-6394a90a32ccSPL ID 2d02613b-bc31-bf2c-e063-6394a90a32ccSPL set ID 2ca373c1-4dba-4126-8616-5c533d606fe5RxCUI 1093060, 1093073UNII 1B8447E7YIUPC 0307130885300, 0307130885096
Pharmacologic class: Estrogen Agonist/Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400713088509 followed by a unit qualifier and the quantity

Package 00713-0885-09. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 31, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Clomiphene citrate is indicated for the treatment of ovulatory dysfunction in women desiring pregnancy. Impediments to achieving pregnancy must be excluded or adequately treated before beginning clomiphene citrate therapy. Those patients most likely to achieve success with clomiphene therapy include patients with polycystic ovary syndrome (see WARNINGS : Ovarian Hyperstimulation Syndrome ), amenorrhea-galactorrhea syndrome, psychogenic amenorrhea, post-oral-contraceptive amenorrhea, and certain cases of secondary amenorrhea of undetermined etiology. Properly timed coitus in relationship to ovulation is important. A basal body temperature graph or other appropriate tests…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 075528

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 075528
Product	Strength	Form · route	Labeler	Product NDC
Clomidclomiphene citrate	Clomiphene citrate 50 mg/1	TabletOral	A-S Medication Solutions	50090-6500
Clomiphene Citrate	Clomiphene citrate 50 mg/1	TabletOral	Cosette Pharmaceuticals NC Laboratories, LLC	83390-107